BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11785106)

  • 1. [Tumor growth index as an integral criterion for the efficacy of antineoplastic therapy under experimental conditions].
    Stukov AN; Ivanova MA; Nikitin AK; Sorokin GM; Kon'kov SA
    Vopr Onkol; 2001; 47(5):616-8. PubMed ID: 11785106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tumor angiogenesis factor (TAF) in the tumor growth. Pathological aspects.
    Hălălău F; Ghyka G; Haraga L
    Rom J Morphol Embryol; 1990; 36(3-4):189-92. PubMed ID: 2151288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Description of the growth of experimental animal tumors using the Gompertz function].
    Kob D; Kriester A; Günther R
    Radiobiol Radiother (Berl); 1982; 23(5):591-602. PubMed ID: 7156384
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of indirect active immunotherapy of Ehrlich carcinoma].
    De Santana CF; Da Silva IN
    Rev Inst Antibiot (Recife); 1974 Dec; 14(1-2):3-8. PubMed ID: 4471334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Different immunological factors in the therapy of an experimental tumor].
    Nicolin A; Frontini E; Olivani P
    Boll Ist Sieroter Milan; 1971; 50(4):295-8. PubMed ID: 5163498
    [No Abstract]   [Full Text] [Related]  

  • 6. [A study of the cell cycle in the rat transplantable ascitic tumor (strain OIa)].
    Barkan RS; Levin VL
    Tsitologiia; 1966; 8(5):615-21. PubMed ID: 5974625
    [No Abstract]   [Full Text] [Related]  

  • 7. Subpopulations of mononuclear leukocytes associated with inhibition of Ehrlich ascites tumor growth by treatment with Bothrops jararaca venom.
    de Vieira Santos MM; da Silva RJ; da Silva MG; Fecchio D
    Mediators Inflamm; 2004 Feb; 13(1):29-32. PubMed ID: 15203562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic inhibition of tumor growth by soluble Flk-1 gene therapy combined with cisplatin.
    Wang R; Zhang XW; Wang GQ; Chen XC; Tian L; Yang HS; Hu M; Peng F; Yang JL; He QM; Zhang W; Jiang Y; Deng HX; Wen YJ; Li J; Zhao X; Wei YQ
    Cancer Gene Ther; 2006 Oct; 13(10):940-7. PubMed ID: 16799469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiments to improve the oncolysis-effect of clostridial-strain M55 (author's transl)].
    Möse JR
    Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):541-5. PubMed ID: 543354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic product with an inhibitory effect on an experimental neoplastic disease.
    Komis A; Petrescu A; Athanasiu P; Stoian M
    Rev Roum Inframicrobiol; 1971; 8(4):281-2. PubMed ID: 4949056
    [No Abstract]   [Full Text] [Related]  

  • 11. Alteration of tumor cell and hepatic parenchymal cell mitotic rates in tumor-injected partially hepatectomized mice.
    Rosene GL
    Cancer Res; 1968 Aug; 28(8):1469-77. PubMed ID: 4876976
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of antitumor drugs of natural origin on the intramuscular and subcutaneous form of five transplantable tumor models.
    Maneva K; Ilarionova M; Todorov D; Silyanovska K
    Biomedicine; 1981 Mar; 35(1):25-7. PubMed ID: 7236845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative studies on the growth behavior of diploid Ehrlich and MCa-1 ascites tumors in the mouse].
    Tillmann B; Lennartz KJ; Eder M
    Z Krebsforsch; 1968; 70(4):295-302. PubMed ID: 4233642
    [No Abstract]   [Full Text] [Related]  

  • 14. [The combined effect of peplomycin and X-ray irradiation].
    Munenaga Y
    Hiroshima Daigaku Shigaku Zasshi; 1984 Jun; 16(1):23-35. PubMed ID: 6206126
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the effect of 6-azauracilriboside in the irradiation of experimental animal tumors].
    Magdon ; Konopatzky R
    Arch Geschwulstforsch; 1967; 29(3):259-65. PubMed ID: 5595236
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the thermic resistance of cancer cells after repeated extreme hyperthermia. Study on moe Ehrlich ascites carcinoma].
    von Ardenne M; Reitnauer PG
    Arch Geschwulstforsch; 1965; 26(4):255-9. PubMed ID: 5887676
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth dependent changes of glycolipid compositions of mouse ascites tumor cells.
    Egawa K; Choi YS; Tanino T
    Jpn J Exp Med; 1975 Jun; 45(3):155-9. PubMed ID: 1177358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kinetic changes in the cellular proliferation of Ehrlich ascites tumor as affected by low-intensity laser radiation].
    Moskalik KG; Kozlov AP
    Tsitologiia; 1980 Dec; 22(12):1447-50. PubMed ID: 7210183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined effect of an Ehrlich ascites tumor growth-inhibiting extract and adrenaline on cell division by that tumor in vitro].
    Romanov IuA; Biks KA; Stepanova LI; Matsak NIa
    Biull Eksp Biol Med; 1981 Feb; 91(2):202-4. PubMed ID: 7225558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor activities of 1-Acetyl-3-o-Toluyl-5-Fu.
    Okada T
    Hiroshima J Med Sci; 1979 Mar; 28(1):49-66. PubMed ID: 457437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.